Kim, R. D., Lewis, C., Bubie, A., Zhang, N., Clemens, K. (2025). Real-world survival differences in advanced biliary tract cancer patients with ctDNA detected IDH1 mutations and FGFR2 fusions receiving first-line gemcitabine-cisplatin with and without immunotherapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.4_suppl.548